Predictive value of natriuretic peptides in dogs with mitral valve disease

Inge Tarnow, Lisbeth Høier Olsen, Clarence Kvart, Katja Hoglund, Sophia Gry Moesgaard, Thea Sigbrit Kamstrup, Henrik Duelund Pedersen, Jens Häggström

    62 Citations (Scopus)

    Abstract

    Natriuretic peptides are useful in diagnosing heart failure in dogs. However, their usefulness in detecting early stages of myxomatous mitral valve disease (MMVD) has been debated. This study evaluated N-terminal (NT) fragment pro-atrial natriuretic peptide (NT-proANP) and NT-pro-brain natriuretic peptide (NT-proBNP) in 39 Cavalier King Charles Spaniels (CKCS) with pre-clinical mitral valve regurgitation (MR), sixteen dogs with clinical signs of heart failure (HF) and thirteen healthy control dogs. Twenty seven CKCS and ten control dogs were re-examined 4 years after the initial examination and the status of the dogs 5 years after the initial examination was determined by telephone calls to the owner. All dogs were evaluated by clinical examination and echocardiography. CKCS with severe MR had higher NT-proANP and NT-proBNP compared to controls and CKCS with less severe MR. Dogs with clinical signs of HF had markedly elevated NT-proANP and NT-proBNP. Plasma concentrations of the natriuretic peptides measured at re-examination could predict progression in regurgitant jet size.
    Original languageEnglish
    JournalVeterinary Journal
    Volume180
    Issue number2
    Pages (from-to)195-201
    Number of pages7
    ISSN1090-0233
    DOIs
    Publication statusPublished - 2009

    Fingerprint

    Dive into the research topics of 'Predictive value of natriuretic peptides in dogs with mitral valve disease'. Together they form a unique fingerprint.

    Cite this